CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 161 enrolled
Drug / intervention
9618X investigational lipid eye drops +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03995355
NCT03995355N/ACompleted
CompareCT.gov

Clinical Evaluation of an Investigational Lipid Drop in Non-contact Lens Wearing Patients

Johnson & Johnson Vision Care, Inc.·interventional·Posted Jun 24, 2019·Updated Jul 3, 2023

In Brief

A clinical study evaluating 9618X investigational lipid eye drops and Blink® Tears for Visual Acuity. Completed, enrolled 161 participants across 1 site.

Detailed Summary

This is a double-masked, randomized, bilateral, 2-Arm parallel group study. Subjects are scheduled for 3 study visits (screening/baseline, 7-Day and 30-Day follow-up visits) over a period of one month.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsVisual Acuity
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedJun 24, 2019
Enrollment StartJun 26, 2019
Primary CompletionSep 20, 2019
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 7.0 years ago

Interventions

9618X investigational lipid eye dropsdevice

Test Eye Drops

Blink® Tearsdevice

Control Eye Drops